-
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.
-
Spinal cord sarcoidosis is difficult to diagnose and may be confused with multiple sclerosis and neuromyelitis optica. Treatment response is variable.
-
Transcranial magnetic stimulation of the brain may be a promising new therapy for the treatment of chronic tinnitus.
-
The presence of conjugate eye deviation as measured by CT or MRI in acute stroke patients predicts visuo-spatial neglect. Prismatic therapy produces a cross-modality improvement in left-sided auditory extinction in patients with chronic right-sided stroke.
-
This prospective case series reports on the efficacy and safety of levetiracetam in central nervous system gliomas.
-
This large retrospective study reports an overall poor prognosis for patients with GBM, but treatment was not "state-of-the-art."
-
Prabhakaran S, et al. Symptomatic intracerebral hemorrhage among eligible warfarin-treated patients receiving intravenous tissue plasminogen activator for acute ischemic stroke. Arch Neurol 2010;67: (doi:10.1001/archneurol.2010.25).
-
Health care clinicians and organizations likely will find that the new health care reform bill's positive features outweigh its drawbacks, experts say.
-
-
Examining the three arms of the ACCORD trial; and FDA Actions: clopidogrel, dexlansoprazole, and tamsulosin.
